Continuous Venovenous Hemofiltration
3
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Bioenergetic Balance
Related Conditions
Often studied with 12 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (3)
Bionenergetic Balance During CVVH
Comparison of Biphozyl® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation
Microcirculation in Continuous Venovenous Hemofiltration Patients on the Intensive Care Unit
Research Network
Common Treatments
- Bioenergetic Balance1
- Cvvh With Phoxilium In The Second 48h After Randomization After Previous 48h With Biphozyl1
- Cvvh With Biphozyl In The First 48h After Randomization1
- Cvvh With Biphozyl In The Second 48h After Randomization After Previous 48h With Phoxilium1
- Cvvh With Phoxilium In The First 48h After Randomization1
Active Sponsors
- Frisius Medisch Centrum1
- Medical University Innsbruck1
- Universitair Ziekenhuis Brussel1
Top Investigators
Frisius Medisch Centrum
Medical University Innsbruck
Universitair Ziekenhuis Brussel
Related Conditions
- Acute Kidney Injury2
- Anticoagulation1
- Phoxilium1
- Replacement Fluid1
- Nutrition Therapy1